Impex Healthcare Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 2.50 Cr
as on 16-11-2024
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 103.13 Cr
as on 16-11-2024
- Satisfied Charges ₹ 38.00 Cr
as on 16-11-2024
- Revenue 6.73%
(FY 2023)
- Profit -59.04%
(FY 2023)
- Ebitda -15.06%
(FY 2023)
- Net Worth 42.89%
(FY 2023)
- Total Assets 18.11%
(FY 2023)
About Impex Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 2.50 Cr.
The company currently has active open charges totaling ₹103.13 Cr. The company has closed loans amounting to ₹38.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Abhay Daga, Saurabh Pandey, and Achin Maheshwari serve as directors at the Company.
- CIN/LLPIN
U51900DL2020PTC370176
- Company No.
370176
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Sep 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Impex Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saurabh Pandey  | Director | 27-Apr-2021 | Current |
| Abhay Daga | Director | 19-Sep-2020 | Current |
| Achin Maheshwari | Additional Director | 04-May-2024 | Current |
Financial Performance of Impex Healthcare.
Impex Healthcare Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.73% increase. The company also saw a substantial fall in profitability, with a 59.04% decrease in profit. The company's net worth Soared by an impressive increase of 42.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Impex Healthcare?
In 2023, Impex Healthcare had a promoter holding of 74.00% and a public holding of 26.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vardhman Health Specialities Private LimitedActive 27 years 9 monthsSaurabh Pandey is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 29 Apr 2022 | ₹35.00 Cr | Open |
Axis Bank Limited Creation Date: 27 Aug 2021 | ₹28.05 Cr | Open |
Citi Bank N.A. Creation Date: 20 Jul 2021 | ₹40.00 Cr | Open |
How Many Employees Work at Impex Healthcare?
Impex Healthcare has a workforce of 43 employees as of Apr 25, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Impex Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Impex Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
